BMP-4 REC HU and 19 more items

Fisher Scientific Co LLC has been awarded a purchase order (PO 4800207964) by the University of Nebraska Medical Center, a state institution under the Board of Regents of the University of Nebraska, for scientific supplies and reagents supporting stem cell research. The contract, valued at $19,253.23, was executed on June 4, 2026, with a completion date of June 15, 2026, and performance is located in Omaha, Nebraska. Payment will be made through Nebraska State Treasury warrants under Net 30 terms with a prompt payment discount, and the order qualifies for tax exemption under UNMC's tax exemption number 05-8905401.

The purchase order encompasses human recombinant proteins, growth factors, and specialized cell culture media products. Key line items include human recombinant bone morphogenetic protein-4, vascular endothelial growth factor variants, basic fibroblast growth factor, interleukins, stem cell factor, fms-like tyrosine kinase-3/fms-like kinase-2, thrombopoietin, granulocyte-colony stimulating factor, and erythropoietin, with unit prices ranging from $264.00 to $2,695.49. Additional supplies include StemDiff APEL2 medium, StemPro-34 combo, Gibco StemFlex medium, CD lipid concentrate, and knockout serum replacement reagents. Delivery is on a freight prepaid, F.O.B. destination basis to UNMC General Supply in Omaha.